Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13347413 | 0.89 | CHRNA7 (0.42) | MAPTRAB9AMEN1MAPK1KMT2A | |
| SCHEMBL190598 | 0.82 | NCEH1 (0.47) | MAPTCYP2A6LMNATDP1RAB9A | |
| SCHEMBL13043497 | 0.79 | ACHE (0.44) | MAPTLMNATDP1RAB9AMEN1 | |
| SCHEMBL3085551 | 0.78 | TRPA1 (0.36) | ALDH1A1SLC6A4 | |
| SCHEMBL3937179 | 0.77 | GABRA1 (0.32) | — | |
| SCHEMBL198322 | 0.77 | L3MBTL1 (0.41) | MAPTCYP2A6LMNARAB9AMEN1 | |
| SCHEMBL15974368 | 0.77 | — | — | |
| SCHEMBL20594015 | 0.77 | — | — | |
| SCHEMBL7354814 | 0.77 | APP (0.35) | CA1CA2CA9SLC6A4 | |
| SCHEMBL15974976 | 0.77 | ESR2 (0.44) | MAPTLMNARAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111808006-B | Nitrogen heterocyclic ring allyl compound and preparation method and application thereof | 暨南大学 | 2023-04-07 | — | — | CN | claimed |
| CN-111808006-A | Nitrogen heterocyclic ring allyl compound and preparation method and application thereof | 暨南大学 | 2020-10-23 | — | — | CN | claimed |
| WO-2023248253-A1 | A NEW LIGAND SCAFFOLD (PY-PYRI) FOR THE META BORYLATION OF PHENOL DERIVATIVES | CENTRE OF BIOMEDICAL RESEARCH (IN) | 2023-12-28 | — | — | WO | disclosed |
| CN-114516789-B | Cyclopropenones micromolecule compound and synthetic method and application thereof | 暨南大学 | 2023-12-05 | — | — | CN | disclosed |
| CN-111808006-B | Nitrogen heterocyclic ring allyl compound and preparation method and application thereof | 暨南大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-114516789-A | Cyclopropenone micromolecule compound and synthetic method and application thereof | 暨南大学 | 2022-05-20 | — | — | CN | disclosed |
| CN-111808006-A | Nitrogen heterocyclic ring allyl compound and preparation method and application thereof | 暨南大学 | 2020-10-23 | — | — | CN | disclosed |
| US-9978473-B2 | Doping methods for hole injection and transport layers | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9978473-B2 | Doping methods for hole injection and transport layers | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| EP-2457913-B1 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | SIGNAL PHARM LLC (US) | 2017-04-19 | — | — | EP | disclosed |
| EP-2090577-B1 | Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors | SIGNAL PHARM LLC (US) | 2017-04-05 | — | — | EP | disclosed |
| US-6025382-A | Antithrombotic diamines | ELI LILLY AND COMPANY (US) | 2000-02-15 | — | — | US | disclosed |
| EP-0973517-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1999045927-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-09-16 | — | — | WO | disclosed |
| EP-0863755-A4 | ANTITHROMBOTIC DIAMINES | LILLY CO ELI (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1998048798-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048794-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998048804-A1 | ANTITHROMBOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| EP-0863755-A1 | ANTITHROMBOTIC DIAMINES | ELI LILLY AND COMPANY (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997025033-A1 | ANTITHROMBOTIC DIAMINES | ELI LILLY AND COMPANY (US) | 1997-07-17 | — | — | WO | disclosed |